How effective is Azulfidine for Joint Inflammation (Arthritis)? (a real world drug study)
Summary:
Overall ratings: 2.6/5 Long term ratings: 3/5
This is a phase IV clinical study of how effective Azulfidine (sulfasalazine) is for Joint inflammation and for what kind of people. The study is created by eHealthMe from 5 Azulfidine users and is updated continuously.
What is Azulfidine?
Azulfidine has active ingredients of sulfasalazine. It is often used in rheumatoid arthritis. eHealthMe is studying from 7,997 Azulfidine users. Check the latest studies of Azulfidine.
What is Joint inflammation?
Joint inflammation is found to be associated with 2,716 drugs and 2,332 conditions by eHealthMe. Check the latest studies of Joint inflammation.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
5 people are studied for taking Azulfidine in Joint inflammation
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Azulfidine effectiveness for Joint inflammation (number of people):
Overall:
- not at all: 1
- somewhat: 1
- moderate: 2
- high: 1
- very high: 0
Long Term:
- not at all: 0
- somewhat: 0
- moderate: 1
- high: 0
- very high: 0
Gender of people who take Azulfidine for Joint inflammation *:
- female: 100 %
- male: 0.0 %
Age of people who take Azulfidine for Joint inflammation *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 20 %
- 20-29: 0.0 %
- 30-39: 20 %
- 40-49: 20 %
- 50-59: 40 %
- 60+: 0.0 %
Who find Azulfidine more effective for Joint Inflammation?
Gender of people who take Azulfidine for Joint inflammation *:
- female: 100 %
- male: 0.0 %
Age of people who take Azulfidine for Joint inflammation *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 100 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 0.0 %
* Approximation only. Some reports may have incomplete information.
Do you take Azulfidine?
- You can start a phase IV clinical trial to monitor Azulfidine safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Alternative drugs to, pros and cons of:
- Azulfidine (7,997 reports)
Treatments, associated drugs and conditions:
- Joint inflammation (188,668 reports)
How the study uses the data?
The study is based on sulfasalazine (the active ingredients of Azulfidine) and Azulfidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Alphagan and Vicodin Es - now
- Tasigna and Lacrimation Increased for Men aged 60+ - 2 seconds ago
- Psoriasis and The Flu - 2 seconds ago
- Could Docetaxel cause Monocyte Count Decreased? - 12 seconds ago
- Drug interactions of Dovonex and Metformin - 12 seconds ago
- Lovastatin and Depression Aggravated for Women aged 40-49 - 12 seconds ago
- Drug interactions of Spiriva and Vesicare - 15 seconds ago
- Ultram Er vs. Morphine, side effect and effectiveness comparison - 16 seconds ago
- Citalopram Hydrobromide and Depakote drug interactions for women aged 60+ - 17 seconds ago
- Cranberry and Wound for Women aged 60+ - 19 seconds ago